Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
May 21, 2024 08:45 ET | Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
April 23, 2024 08:00 ET | Dalrada Financial Corp.
OTCQB: DFCO subsidiary announces entry into the global weight loss drug market currently worth approximately $6 billion